| Nanotechnology-based vaccines for allergen-specific immunotherapy: Potentials and challenges of conventional and novel adjuvants under research L Johnson, A Duschl, M Himly Vaccines 8 (2), 237, 2020 | 38 | 2020 |
| Mechanisms of particles in sensitization, effector function and therapy of allergic disease IA Joubert, M Geppert, L Johnson, R Mills-Goodlet, S Michelini, ... Frontiers in Immunology 11, 1334, 2020 | 23 | 2020 |
| The impact of nanoparticles on innate immune activation by live bacteria BJ Swartzwelter, AC Fux, L Johnson, E Swart, S Hofer, N Hofstätter, ... International Journal of Molecular Sciences 21 (24), 9695, 2020 | 22 | 2020 |
| Computational prediction and experimental analysis of the nanoparticle-protein corona: Showcasing an in vitro-in silico workflow providing FAIR data I Hasenkopf, R Mills-Goodlet, L Johnson, I Rouse, M Geppert, A Duschl, ... Nano Today 46, 101561, 2022 | 17 | 2022 |
| Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations S Hofer, N Hofstätter, B Punz, I Hasenkopf, L Johnson, M Himly Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 14 (6 …, 2022 | 14 | 2022 |
| EVAnalyzer: High content imaging for rigorous characterisation of single extracellular vesicles using standard laboratory equipment and a new open‐source ImageJ/Fiji plugin M Schürz, J Danmayr, M Jaritsch, E Klinglmayr, HM Benirschke, CT Matea, ... Journal of Extracellular Vesicles 11 (12), 12282, 2022 | 11 | 2022 |
| Mechanistic investigations into the encapsulation and release of small molecules and proteins from a supramolecular nucleoside gel in vitro and in vivo MGF Angelerou, R Markus, V Paraskevopoulou, R Foralosso, P Clarke, ... Journal of Controlled Release 317, 118-129, 2020 | 11 | 2020 |
| Surface functionalization of silica nanoparticles: strategies to optimize the immune-activating profile of carrier platforms B Punz, L Johnson, M Geppert, HH Dang, J Horejs-Hoeck, A Duschl, ... Pharmaceutics 14 (5), 1103, 2022 | 9 | 2022 |
| The nanotopography of SiO 2 particles impacts the selectivity and 3D fold of bound allergens R Mills-Goodlet, L Johnson, IJ Hoppe, C Regl, M Geppert, M Schenck, ... Nanoscale 13 (48), 20508-20520, 2021 | 8 | 2021 |
| Mechanistic insights into silica nanoparticle–allergen interactions on antigen presenting cell function in the context of allergic reactions L Johnson, L Aglas, B Punz, HH Dang, C Christ, L Pointner, M Wenger, ... Nanoscale 15 (5), 2262-2275, 2023 | 5 | 2023 |
| Structural alterations of antigens at the material interface: An early decision toolbox facilitating safe-by-design nanovaccine development L Johnson, L Aglas, WT Soh, M Geppert, S Hofer, N Hofstätter, P Briza, ... International Journal of Molecular Sciences 22 (19), 10895, 2021 | 5 | 2021 |
| Low molecular weight nucleoside Gelators: a platform for protein aggregation inhibition L Johnson, MG Faidra Angelerou, BT Surikutchi, S Allen, M Zelzer, ... Molecular Pharmaceutics 16 (1), 462-467, 2018 | 5 | 2018 |
| Humanized mediator release assay as a read-out for allergen potency M Wenger, A Bethanis, L Johnson, L Aglas JoVE (Journal of Visualized Experiments), e62702, 2021 | 4 | 2021 |
| Alignment of protein corona prediction from physics-based models with experimental analysis: showcasing an in vitro-in silico workflow providing FAIR data I Hasenkopf, RD Mills-Goodlet, L Johnson, M Geppert, I Rouse, ... Nano Today, 2022 | 1 | 2022 |
| Reducing the solubility of the major birch pollen allergen Bet v 1 by particle-loading mitigates Th2 responses A Kraiem, E Pelamatti, S Grosse-Kathoefer, H Demir, U Vollmann, ... Allergology International, 2024 | | 2024 |
| Instance maps as an organising concept for complex experimental workflows as demonstrated for (nano) material safety research B Punz, M Brajnik, J Dokler, JD Amos, L Johnson, K Reilly, ... Beilstein Archives 2024 (1), 26, 2024 | | 2024 |
| & nbsp; Mechanisms of Particles in Sensitization, Effector Function and Therapy of Allergic Disease (vol 11, 1334, 2020) IA Joubert, M Geppert, L Johnson, R Mills-Goodlet, S Michelini, A Duschl, ... FRONTIERS IN IMMUNOLOGY 13, 2022 | | 2022 |
| In vitro immuno-nanotoxicological methods that take pre-existing conditions into account M Himly, L Johnson, R Mills-Goodlet, I Hasenkopf, S Hofer, N Hofstaetter, ... Toxicology Letters 350, S20, 2021 | | 2021 |
| A toolbox for early-stage suitability assessment of (nano-) particulate systems in AIT vaccine development L Johnson, L Aglas, WT Soh, M Geppert, S Hofer, N Hofstätter, P Briza, ... 15th World Immune Regulation Meeting 2021, 2021 | | 2021 |
| Studying the stages of immune activation/modulation by silica nanoparticle-allergen conjugates: applying the AOP concept to immunotherapy development L Johnson, L Aglas, M Geppert, S Hofer, N Hofstätter, WT Soh, F Ferreira, ... NanoSafe Digital Conference 2020, 2020 | | 2020 |
